NCT03047395 · Interventional trial
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
Overall registry status Completed
Phase 3
Conditions Psoriasis
Delaware Valley sites
- Paddington Testing Co., Inc. /ID# 154022 · Philadelphia, PA · Philadelphia County
- Psoriasis Treatment Center of Central New Jersey /ID# 154001 · East Windsor, NJ · Mercer County
First posted
Registry updated
Added to the directory